BioNTech sees potential to supply 3 billion doses in 2022
NEW YORK (BLOOMBERG) - BioNTech could have capacity to make three billion doses of Covid-19 vaccine with United States partner Pfizer next year, the German company's chief executive officer said, making their pioneering shot far more widely available around the world.
……Read full article on The Straits Times - World
Health
One-stop lifestyle app dedicated to making life in Singapore a breeze!
English
简体中文
Comments
Leave a comment in Nestia App